Therapeutics: CC chemokine receptor 5 (CCR5; CD195)

Cancer

INDICATION: Prostate cancer

Mouse studies suggest CCR5 antagonists could help prevent prostate cancer

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE